Georgios K Glantzounis Selected Research

Adenocarcinoma

6/2017	Minimally Invasive Surgical Approaches for Pancreatic Adenocarcinoma: Recent Trends.
1/2017	From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers.
2/2014	BMI and lymph node ratio may predict clinical outcomes of gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Georgios K Glantzounis Research Topics

Disease

6	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2017
6	Neoplasms (Cancer) 11/2022 - 01/2017
4	Ischemia 11/2022 - 03/2007
3	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2017
3	Carcinogenesis 01/2022 - 04/2017
3	Adenocarcinoma 06/2017 - 02/2014
3	Reperfusion Injury 10/2009 - 09/2005
2	Stomach Neoplasms (Stomach Cancer) 05/2018 - 04/2017
1	Septic Shock (Toxic Shock Syndrome) 08/2023
1	Ascites 08/2023
1	Sepsis (Septicemia) 08/2023
1	Thoracic Aortic Aneurysm 06/2023
1	Abdominal Aortic Aneurysm 05/2023
1	Aortic Aneurysm (Aneurysm, Aortic) 06/2022
1	Colorectal Neoplasms (Colorectal Cancer) 03/2022
1	Metaplasia 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Respiratory Acidosis 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Liver Neoplasms (Liver Cancer) 12/2021
1	Margins of Excision 09/2021
1	Hepatitis B 07/2021
1	Infections 07/2021
1	Virus Diseases (Viral Diseases) 07/2021
1	Surgical Wound Infection 04/2021
1	Wounds and Injuries (Trauma) 04/2021
1	Cross Infection (Nosocomial Infection) 04/2021
1	Obesity 11/2020
1	Non-alcoholic Fatty Liver Disease 11/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2020
1	Cholangiocarcinoma 10/2017
1	Overweight 02/2014
1	Thrombosis (Thrombus) 04/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2007
1	Hemorrhagic Shock 09/2005

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2017
3	salicylhydroxamic acid (SHAM)IBA 01/2022 - 03/2007
3	Biomarkers (Surrogate Marker)IBA 04/2017 - 01/2017
2	RNA (Ribonucleic Acid)IBA 03/2022 - 10/2017
1	AlbuminsIBA 08/2023
1	NitrogenIBA 08/2023
1	Urea (Carbamide)FDA LinkGeneric 08/2023
1	IronIBA 11/2022
1	Isoflurophate (DFP)FDA Link 11/2022
1	Deferoxamine (Desferal)FDA LinkGeneric 11/2022
1	DeferiproneIBA 11/2022
1	Chelating AgentsIBA 11/2022
1	Contrast MediaIBA 06/2022
1	8-hydroxyguanineIBA 03/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	LeptinIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021
1	Antiviral Agents (Antivirals)IBA 07/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2021
1	Serum AlbuminIBA 04/2021
1	Explosive Agents (Explosives)IBA 11/2019
1	Cell-Free Nucleic AcidsIBA 11/2019
1	ParaffinIBA 11/2018
1	Gemcitabine FDA Link 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Adenosine Monophosphate (AMP)IBA 01/2017
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2007
1	S-NitrosothiolsIBA 03/2007
1	AntioxidantsIBA 09/2005

Therapy/Procedure

4	Hepatectomy 09/2021 - 02/2017
3	Laparotomy 08/2023 - 03/2007
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
3	Therapeutics 12/2021 - 09/2005
3	Liver Transplantation 11/2020 - 04/2011
2	Gastrectomy 05/2018 - 02/2014
1	Endovascular Aneurysm Repair 06/2023
1	Prostheses and Implants (Prosthesis) 05/2023
1	Length of Stay 04/2021
1	Chemoprevention 04/2021
1	Adjuvant Chemotherapy 11/2018
1	Lymph Node Excision (Lymph Node Dissection) 01/2018
1	Pancreaticoduodenectomy 06/2017
1	Vascular Access Devices (Arterial Line) 10/2009
1	Catheters 10/2009
1	Resuscitation 09/2005
1	Transplantation 09/2005